Medtronic plc Non-GAAP EPS of $1.26 beats by $0.03, revenue of $8.5B beats by $130M

* Medtronic plc press release [https://seekingalpha.com/pr/20204563-medtronic-reports-first-quarter-fiscal-2026-financial-results] (NYSE:MDT [https://seekingalpha.com/symbol/MDT]): Q1 Non-GAAP EPS of $1.26 beats by $0.03.
* Revenue of $8.5B (+7.5% Y/Y) beats by $130M.
* FY26 revenue growth on a reported basis would be in the range of 6.5% to 6.8%.
* Medtronic now expects underlying FY26 diluted non-GAAP EPS growth to be approximately 4.5% versus the prior guidance of approximately 4%. Including the reduced potential impact from tariffs of approximately $185 million versus the prior range of approximately $200 million to $350 million, Medtronic is raising its FY26 diluted non-GAAP EPS guidance to the new range of $5.60 to $5.66 vs $5.55 consensus versus the prior range of $5.50 to $5.60.

MORE ON MEDTRONIC PLC

* Medtronic: Diabetes Business Spin-Off Key To Overcoming Stagnation [https://seekingalpha.com/article/4808545-medtronic-diabetes-business-spin-off-key-to-overcoming-stagnation]
* Medtronic: Growth Challenges Persist [https://seekingalpha.com/article/4806694-medtronic-growth-challenges-persist]
* Medtronic: Cash Flow Strength Balanced By Execution Risks [https://seekingalpha.com/article/4798877-medtronic-cash-flow-strength-balanced-by-execution-risks]
* Medtronic to change board as Elliott takes stake - report [https://seekingalpha.com/news/4486868-medtronic-to-change-board-as-elliott-takes-stake---report]
* Medtronic heads into Q1 with softer profit sentiment [https://seekingalpha.com/news/4486572-medtronic-heads-into-q1-with-softer-profit-sentiment]